CAPLA Study: Catheter ablation for persistent atrial fibrillation. A Multicentre randomised study of pulmonary vein antral isolation (PVAI) alone vs PVAI with posterior Left Atrial wall isolation (PWI)

CAPLA 研究：导管消融治疗持续性心房颤动。

• 批准号: nhmrc : GNT1134023
• 负责人: Dr Hariharan Sugumar
• 金额: $ 12.47万
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/capla-study-catheter-isolation-pwi/1347932
• 关键词: CAPLA; Study; Catheter; ablation; persistent

Atrial fibrillation (AF) is a common heart rhythm abnormality that affects quality of life with added health care costs. A minimally invasive procedure called catheter ablation (CA) is effective in controlling simple AF (paroxysmal AF) but the best ablation strategy to control a more resistant form of AF (Persistent AF) is unknown. This trial has been designed to address this key gap in knowledge by assessing if adding specific additional ablation to CA will improve outcomes.

心房颤动（AF）是一种常见的心律异常，它会因增加的医疗保健费用而影响生活质量。一种称为导管消融（CA）的最小侵入性程序可有效控制简单的AF（阵发性AF），但是控制AF（持久性AF）的更具抗性形式的最佳消融策略是未知的。该试验旨在通过评估在CA上增加特定的额外消融将改善结果，以解决知识中的关键差距。